Turk Ilac ve Serum Sanayi AS Cash Flow Reinvestment Rate
Turk Ilac ve Serum Sanayi AS cash flow reinvestment rate. Turk Ilac ve Serum Sanayi AS (TRILC) has a Cash Flow Reinvestment Rate of 4.39x as of September 2025, reinvesting TL195.46 Million (capex TL142.42 Million plus investments TL-53.05 Million) from operating cash flow of TL44.50 Million. Explore TRILC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Turk Ilac ve Serum Sanayi AS (2018–2023)
Cash flow reinvestment rate of Turk Ilac ve Serum Sanayi AS from 2018 to 2023. Historical reinvestment intensity for Turk Ilac ve Serum Sanayi AS across 4 annual periods. Explore TRILC capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Turk Ilac ve Serum Sanayi AS Cash Flow Reinvestment Rate by Year (2018–2023)
Turk Ilac ve Serum Sanayi AS cash flow reinvestment rate by year from 2018 to 2023. Year-by-year capital reinvestment analysis for Turk Ilac ve Serum Sanayi AS. For the full cash flow conversion analysis, see how efficiently does Turk Ilac ve Serum Sanayi AS generate cash.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.56x | TL230.62 Million | TL408.19 Million | TL115.31 Million | ▼ -39.8% |
| 2020 | 0.94x | TL31.14 Million | TL33.20 Million | TL16.54 Million | ▼ -73.7% |
| 2019 | 3.56x | TL47.45 Million | TL13.32 Million | TL24.92 Million | ▲ +927.5% |
| 2018 | 0.35x | TL13.22 Million | TL38.13 Million | TL0.00 | — |